Label: ELLOCY WART REMOVER- wart remover liquid

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated September 2, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active Ingredient

    Salicylic acid 1%

  • Purpose

    remove wart

  • Use

    • for removal of common and plantar warts
    • the plantar wart is recognized by its location only on the bottom of the foot, its tenderness, and the interruption of the footprint pattern

  • Warnings

    For external use only

  • Do not use

    • On damaged skin (cuts, abrasions, eczema, sunburn).
    • If you are pregnant or breastfeeding

  • When Using

    • Aviod contact with eyes.If product gets into the eyes, flush with water for 15 minutes.• If irritation persists, seek medical attention immediately.

  • Stop Use

    if irritation occurs
    if an allergic reaction occurs

  • Ask Doctor

    if you are pregnant or breastfeeding
    if you have diabetes

  • Keep Oot Of Reach Of Children

    Keep Out Of Reach Of Children

  • Directions

    • wash the affected area.
    • dry thoroughly
    • apply 2 times a day (2-3 applications each time).
    • continue application for 5-7 days.

  • Other information

    Store between 20 to 25℃ (68 to 77F)
    Protect from excessive heat above 40℃ (104F)

  • Inactive ingredients

    Fritillaria extract, Purslane extract, Safflower, Willow bark extract, Lactic acid, Borneol, Dimethyl sulfoxide, Chlorhexidine acetate

  • Questions

    CUSTOMER SUPPORT Contact us at support@ellocy.com

  • PRINCIPAL DISPLAY PANEL

    1

  • INGREDIENTS AND APPEARANCE
    ELLOCY WART REMOVER 
    wart remover liquid
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:83596-004
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID1 g  in 100 mL
    Inactive Ingredients
    Ingredient NameStrength
    WILLOW BARK (UNII: S883J9JDYX)  
    FRITILLARIA DELAVAYI BULB (UNII: AG6Q756AT7)  
    SAFFLOWER (UNII: 4VBL71TY4Y)  
    DIMETHYL SULFOXIDE (UNII: YOW8V9698H)  
    PURSLANE (UNII: M6S840WXG5)  
    BORNEOL (UNII: M89NIB437X)  
    WATER (UNII: 059QF0KO0R)  
    LACTIC ACID (UNII: 33X04XA5AT)  
    CHLORHEXIDINE ACETATE (UNII: 5908ZUF22Y)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:83596-004-015 mL in 1 BOTTLE; Type 0: Not a Combination Product09/02/2024
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM02809/02/2024
    Labeler - Aramode (963192477)
    Establishment
    NameAddressID/FEIBusiness Operations
    Aramode963192477manufacture(83596-004)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!